Tag Archives: CTCL
Clinical Trials Starting Soon for Mesothelioma Drug
Scientists and cancer researchers conducting a new stage in the clinical trials for the drug Vorinostat are looking for patients willing to test out this experimental treatment. With the successful completion of Phase II trials, Merck & Co., the company that manufactures the drug under the brand name Zolinza has announced that their research into [...]
Posted in Mesothelioma News, Treatment News
Tagged Asbestos, CTCL, diagnosis, exposure, HIV, Merck Co, Mesothelioma, National Cancer Institute, Sources Merck
Comments Off
